Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2030

Conditions
Congestive Heart Failure
Interventions
DRUG

AB-1002

Intracoronary Infusion of AB-1002 or placebo

Trial Locations (46)

4021

RECRUITING

Kardiologie & Intensivmedizin Campus III, Linz

5020

ACTIVE_NOT_RECRUITING

SALK University Hospital, Salzburg

8010

RECRUITING

Medizinische Universität Graz, Graz

8908

ACTIVE_NOT_RECRUITING

Hospital Universitario de Bellvitge, Barcelona

9101

RECRUITING

Radboud University Medical Center, Nijmegen

10029

NOT_YET_RECRUITING

Mt. Sinai New York, New York

11794

RECRUITING

Stony Brook, Stony Brook

15353

RECRUITING

Charité Universitaetsmedizin, Berlin

15706

ACTIVE_NOT_RECRUITING

Complejo Hospitalario Universitario Santiago de Compostela (CHUS), Santiago de Compostela

18103

RECRUITING

LVH Cardiology, Allentown

28046

RECRUITING

Universidad Autonoma de Madrid (UAM) - Hospital Universitario La Paz (HULP), Madrid

28204

NOT_YET_RECRUITING

Sanger Heart and Vascular Institute, Charlotte

29425

RECRUITING

Medical University of South Carolina (MUSC) Medical Center, Charleston

30625

RECRUITING

Medizinische Hochschule Hannover (MHH), Hanover

30912

RECRUITING

Augusta University, Augusta

31008

ACTIVE_NOT_RECRUITING

Universidad de Navarra - Clinica Universidad de Navarra (CUN), Pamplona

32610

RECRUITING

University of Florida, Gainesville

33146

RECRUITING

University of Miami, Coral Gables

33756

RECRUITING

Baycare Medical Group, Clearwater

35211

NOT_YET_RECRUITING

Cardiology P.C. Birmingham, Birmingham

38138

RECRUITING

Stern Cardiovascular, Germantown

43210

RECRUITING

The Ohio State University, Columbus

45219

RECRUITING

The Christ Hospital / The Linder Center for Research, Cincinnati

RECRUITING

University of Cincinnati, Cincinnati

46010

RECRUITING

Hospital Clinico Universitario de Valencia (CHUV), Valencia

52242

NOT_YET_RECRUITING

University of Iowa, Iowa City

53792

NOT_YET_RECRUITING

University of Wisconsin, Madison

55407

RECRUITING

Minneapolis Heart Institute Foundation, Minneapolis

55905

RECRUITING

Mayo Clinic - Minnesota, Rochester

60181

RECRUITING

Loyola Medicine Burr Ridge, Oakbrook Terrace

63117

RECRUITING

St. Louis University, St Louis

66160

RECRUITING

University of Kansas Medical Center (KUMC), Kansas City

75246

RECRUITING

Baylor Scott & White Advanced Heart Failure Clinic - Dallas, Dallas

77030

RECRUITING

Baylor College of Medicine (BCM) - Baylor Heart Clinic, Houston

NOT_YET_RECRUITING

Houston Methodist Debakey Cardiology Associates, Houston

89502

RECRUITING

Renown Health, Reno

92093

RECRUITING

University of California San Diego, La Jolla

98195

RECRUITING

University of Washington, Seattle

Unknown

RECRUITING

NÖ Landesgesundheitsagentur, Sankt Pölten

ACTIVE_NOT_RECRUITING

"Hospital Ramon y Cajal , Cardiology - Research Unit"

D-24105

RECRUITING

Universitätsklinikum Schleswig-Holstein, Kiel

1105 AZ

RECRUITING

Amsterdam UMC - Locatie AMC (Academisch Medisch Centrum), Amsterdam

3015CE

ACTIVE_NOT_RECRUITING

Erasmus Medisch Centrum, Rotterdam

3508GA

RECRUITING

Universitair Medisch Centrum (UMC) Utrecht, Utrecht

M13 9WL

ACTIVE_NOT_RECRUITING

Manchester Royal Infirmary, Manchester

SW3 6LY

ACTIVE_NOT_RECRUITING

Imperial College London - National Heart & Lung Institute (NHLI) - Royal Brompton Campus, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AskBio Inc

INDUSTRY

NCT05598333 - Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure | Biotech Hunter | Biotech Hunter